Women's Malignancies Branch
Information for Patients
Learn more about our clinical trials and the highly specialized care teams who lead them.
Women's Malignancies Branch
About
The Women’s Malignancies Branch (WMB) is committed to developing new treatments for patients with breast and gynecologic malignancies in order to improve the outcomes for patients with these diseases. The members of WMB conduct basic and translational research and integrate laboratory research findings into hypothesis-driven clinical trials for these malignancies. We encourage patients to explore our website and contact us for questions related to our research and clinical trial opportunities.
Clinical Trials
PI & Key Staff
Job Vacancies
| Position | Degree Required | Contact Name | Contact Email |
|---|---|---|---|
| Clinical Research Physician - Clinical trials, ovarian and breast cancer | M.D. or equivalent | Josselyn White | Josselyn.white@nih.gov |
News
Stanley Lipkowitz, M.D., Ph.D. and Yoshimi Greer, M.D., Ph.D. discuss about the paper "ONC201 kills breast cancer cells in vitro by targeting mitochondria" in a video interview
Impact Journals, LLC. Aug.10, 2020
Youtube link - https://youtu.be/55awJT-utxk
Soundcloud podcast - https://soundcloud.com/oncotarget/interview-with-the-national-institutes-of-healths-dr-stanley-lipkowitz-dr-yoshimi-endo-greer
Full text - https://www.oncotarget.com/article/24862/text/
Press release - https://www.oncotarget.com/news/pr/onc201-kills-breast-cancer-cells-in-vitro-by-targeting-mitochondria
Contact
Contact Info
Center for Cancer Research National Cancer Institute
- Building 10, Room 4B54
- Bethesda, MD 20892-1361
- 240-858-3007
- 240-541-4547
